Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.

IV Double and Triple Concentrated Nicardipine for Stroke and ICH

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00325793
Recruitment Status : Unknown
Verified May 2006 by OSF Healthcare System.
Recruitment status was:  Recruiting
First Posted : May 15, 2006
Last Update Posted : May 15, 2006
PDL BioPharma, Inc.
Information provided by:
OSF Healthcare System

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Unknown
Primary Completion Date : No date given
Study Completion Date : No date given
Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 November 22, 2013
January 10, 2014
2 August 22, 2018
August 23, 2018
3 August 26, 2018
September 24, 2018